Atlas Trials

Coronary Heart Disease

513 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Coronary Heart Disease

RecordFirmDate
Pilot Study of a Self-help Intervention for Depression in Patients With a Chronic Disease (NCT00854984)University of Edinburgh2009-03-13
Acarbose Cardiovascular Evaluation Trial (NCT00829660)University of Oxford2009-02-17
Pharmaceutical Follow-up of Coronary Heart Disease (CHD) Patients (NCT01115608)Hospital Pharmacy of North Norway Trust2009-02-01
Treatment of Coronary Heart Disease With Amiloride (NCT01231165)University of Carabobo2009-02-01
Reducing the Pro-ischaemic Effects of Air Pollution Exposure Using a Simple Face Mask (NCT00809653)University of Edinburgh2009-01-01
Global Vascular Effects of Intermittent Pneumatic Compression-Pilot Study (NCT01064323)Johns Hopkins University2009-01-01
Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who Are Not on Apheresis (NCT00794664)Kastle Therapeutics, LLC2009-01-01
The Effect of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery (NCT00788242)Christoph Ellenberger2009-01-01
Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients (NCT00770146)Kastle Therapeutics, LLC2008-11-01
A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease (NCT00786175)Chinese University of Hong Kong2008-10-01
Persantin Preceding Elective PCI (NCT00767663)Radboud University Medical Center2008-10-01
Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction (NCT00738517)University Medicine Greifswald2008-09-01
The Effects of Diesel Exhaust Inhalation On Exercise Capacity In Patients With Stable Angina Pectoris (NCT00737958)University of Edinburgh2008-08-01
Effects of Ambient Air Pollution Exposure in Patients With Stable Angina Pectoris During Normal Daily Activities (NCT00738491)University of Edinburgh2008-08-01
Evaluation of Intervention on Impaired Glucose Tolerance(IGT) in Patients With Coronary Heart Disease. (NCT00724542)Ministry of Science and Technology of the People´s Republic of China2008-07-01
Influence of Periodontal Treatment on Systemic Inflammatory Mediators (NCT01201746)Sheikh Zayed Federal Postgraduate Medical Institute2008-07-01
Recovery of Left Ventricular Function in Chronic Total Occluded Coronary Arteries (NCT01924962)University Heart Center Freiburg - Bad Krozingen2008-05-28
A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome (NCT00658515)Hoffmann-La Roche2008-04-01
Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD) (NCT00817024)Guang'anmen Hospital of China Academy of Chinese Medical Sciences2008-03-01
Efficacy Study of Rapamycin- vs. Zotarolimus-Eluting Stents to Reduce Coronary Restenosis (NCT00598533)Deutsches Herzzentrum Muenchen2008-02-01
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood (NCT00616772)AbbVie (prior sponsor, Abbott)2008-02-01
Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood (NCT00639158)Abbott2008-02-01
Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED) (NCT00723723)Organon and Co2008-01-01
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464) (NCT00730132)Organon and Co2008-01-01
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP (NCT00584350)Université de Sherbrooke2007-11-01
Surgical Manipulation of the Aorta and Cerebral Infarction (NCT00558779)University of Wuerzburg2007-11-01
Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD) (NCT00568594)Novartis2007-11-01
Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease (NCT00552747)National Heart Institute, Mexico2007-10-01
Endothelial Progenitor Cells-capture Stents in Acute Coronary Syndromes (NCT00494247)Silesian School of Medicine2007-10-01
Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death (NCT00524862)Unity Health Toronto2007-10-01
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets (NCT00536796)AstraZeneca2007-09-01
Risk Reduction in Coronary Heart Disease (NCT00679237)Sorlandet Hospital HF2007-09-01
Family Heart Health Program: Randomized, Controlled Trial (NCT00552591)Ottawa Heart Institute Research Corporation2007-09-01
Efficacy of Sterol Enhanced Soy Beverage on Cholesterol Metabolism, Inflammation and Oxidative Status in Humans (NCT00924391)University of Manitoba2007-09-01
3 Limus Agent Eluting Stents With Different Polymer Coating (NCT00598676)Deutsches Herzzentrum Muenchen2007-09-01
12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe (NCT00525824)AstraZeneca2007-08-01
Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets (NCT00536965)AstraZeneca2007-07-01
Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree (NCT00500617)CardioDx2007-07-01
Randomized Trial Comparing Titan Stent With Zotarolimus-Eluting Stent (NCT00492908)University of Bern2007-06-01
Effects of Statin and Ezetimibe Association on Kinetics of Artificial Chilomicrons (NCT00481351)University of Sao Paulo2007-06-01
CD16+ Monocytes in Coronary Heart Disease (CHD) (NCT01442948)Martin-Luther-Universität Halle-Wittenberg2007-05-01
Trial Comparing Home-based Cardiac Rehabilitation With Comprehensive Centre-based Cardiac Rehabilitation in Patients Older Than 65 Years With Coronary Heart Disease. The HOMEBASE Trial (NCT00489801)Bispebjerg Hospital2007-01-01
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381 (NCT00400439)Hoffmann-La Roche2007-01-01
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE (NCT00461630)University of Oxford2007-01-01
Impact of Systematic Nursing Orientations in the Reduction of Predicted Cardiovascular Risk in Patients With Coronary Artery Disease. (NCT00795626)Hospital de Clinicas de Porto Alegre2007-01-01
A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis (NCT00433823)Abant Izzet Baysal University2007-01-01
Comparison of Low and High Phytosterol Diets With Respect to Cholesterol Metabolism (NCT00860509)Washington University School of Medicine2006-11-01
The Effect of Beer, Red Wine and Fruit Juice on Blood Vessel Function in Persons With Cardiovascular Disease (NCT00382551)Aalborg University Hospital2006-10-01
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. (NCT00300430)Abbott2006-09-01
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease (NCT00379808)University of Florida2006-07-01
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study) (NCT00799396)University of Maryland, Baltimore2006-07-01
Cardiovascular Risk Factor Management in HIV Infection (NCT00264394)University Hospital, Basel, Switzerland2006-07-01
A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent. (NCT00353522)Hoffmann-La Roche2006-07-01
Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel (NCT00349661)University Hospital, Brest2006-06-01
Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3) (NCT00350454)Deutsches Herzzentrum Muenchen2006-06-01
Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) (NCT01588470)The University of Texas Health Science Center at San Antonio2006-06-01
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors (NCT00344175)Kowa Research Europe2006-06-01
Dynamic Myocardial Perfusion Imaging by 320 Multidetector Computed Tomography (NCT01368237)University of Edinburgh2006-05-01
Controlled Exposures to Air Pollution in Patients With Coronary Heart Disease (NCT00437138)University of Edinburgh2006-04-01
A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous Intervention (NCT00291902)GlaxoSmithKline2006-03-01
Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood (NCT00300469)Abbott2006-03-01
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood (NCT00300482)Abbott2006-03-01
Addition of Phytosterols to a Low Phytosterol Diet (NCT00860054)Washington University School of Medicine2006-03-01
Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood (NCT00300456)Abbott2006-03-01
A Single Center Prospective Randomized Controlled Clinical Study of JANUS Stent in Patients With Coronary Artery Disease (NCT00406523)Shenyang Northern Hospital2006-02-01
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (NCT00552669)Centro de estudios en Cardiologia Intervencionista2006-01-01
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia (NCT00260338)Rigshospitalet, Denmark2005-12-01
T Wave Alternans in Hemodialysis (NCT00296543)Indiana University2005-10-01
Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740) (NCT00202904)Organon and Co2005-05-01
Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE) (NCT00402636)Deutsches Herzzentrum Muenchen2005-03-01
Post-marketing Study to Collect Safety Data in Heart Transplant Patients Receiving Everolimus (NCT00134940)Novartis2005-01-01
ESCAP: Supervised Exercise for Patients With Coronary Heart Disease in the Primary Care Setting (NCT00146315)Basque Health Service2005-01-01
Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients (NCT00155350)National Taiwan University Hospital2004-11-01
Non Invasive Multicenter Italian Study for Coronary Artery Disease (NCT00539604)Società Italiana di Radiologia Medica2004-07-01
Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg (NCT00653445)AstraZeneca2004-06-01
Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL (NCT00079638)Kos Pharmaceuticals2004-04-01
Analysis of Human Coronary Aspirate (NCT01430884)Universität Duisburg-Essen2004-04-01
Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA (NCT00653042)Scios, Inc.2004-03-01
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease (NCT00235950)AstraZeneca2004-01-01
Long-term Mortality in Diabetics Undergoing Major Surgery (NCT00286572)University Hospital, Basel, Switzerland2004-01-01
Levosimendan Pretreatment for Weaning Patients From Cardio-Pulmonary Bypass (NCT00130871)Orion Corporation, Orion Pharma2004-01-01
Prognosis of Acute Coronary Syndrome in HIV-infected Patients (NCT00139958)Saint Antoine University Hospital2003-11-01
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) (NCT00574782)AstraZeneca2003-09-01
Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis (NCT01119404)Kanta-Häme Central Hospital2003-06-01
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (NCT00660764)AstraZeneca2003-05-01
Polaris - Crestor 40 mg vs Atorvastatin 80 mg for 26 Weeks (NCT00653588)AstraZeneca2003-04-01
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization (NCT00297661)University of Bern2003-04-01
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. (NCT00222261)Ullevaal University Hospital2003-04-01
Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476) (NCT00651274)Organon and Co2003-04-01
Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM) (NCT02803411)Yonsei University2003-03-01
Evaluation of the Efficacy of Rosuvastatin in Daily Practice (TARGET) (NCT00396110)AstraZeneca2003-02-01
Periodontitis and Cardiovascular Events or "PAVE" (NCT00066053)University at Buffalo2003-01-01
Paleolithic Diet in the Treatment of Glucose Intolerance (NCT00419497)Lund University Hospital2003-01-01
Effects of a Mediterranean Style Diet on Vascular Health in Type 2 Diabetes (NCT00163683)Bayside Health2003-01-01
Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease (NCT00185042)Daiichi Sankyo2002-11-01
Heart Rate Variability for Prediction of Perioperative Events (NCT00481234)University Hospital Schleswig-Holstein2002-06-01
Cholesterol and Pharmacogenetic Study (NCT00451828)UCSF Benioff Children's Hospital Oakland2002-03-01
From Research to Practice - Lipid Management for Low HDL-Cholesterol (NCT00057044)US Department of Veterans Affairs2001-10-01
Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD) (NCT00239590)Imperial College London2001-06-01
Effects of Meditation on Mechanism of Coronary Heart Disease (NCT00010738)National Center for Complementary and Integrative Health (NCCIH)1999-09-01
← Previous Next →

Track Coronary Heart Disease automatically

Every clearance here is in the API, with alerts when new ones post.